- Release Date: 03/12/25 09:19
- Summary: Ethics Approval Received for SPONTAN Phase II Clinical Study
- Price Sensitive: Yes
- Download Document 131.72KB
- Forums
- ASX - By Stock
- LTP
- Ann: Ethics Approval Received for SPONTAN Phase II Clinical Study
LTP
ltr pharma limited
Add to My Watchlist
1.71%
!
57.5¢
Ann: Ethics Approval Received for SPONTAN Phase II Clinical Study
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|
|||||
|
Last
57.5¢ |
Change
-0.010(1.71%) |
Mkt cap ! $105.3M | |||
| Open | High | Low | Volume |
| 59.0¢ | 59.5¢ | 57.5¢ | 154.1K |
Buyers (Bids)
| Vol. | Price($) |
|---|---|
| 41937 | 57.5¢ |
Sellers (Offers)
| Price($) | Vol. |
|---|---|
| 59.0¢ | 5000 |
| Last trade - 16.11pm 16/01/2026 (20 minute delay) ? |
Featured News
| LTP (ASX) Chart |